BARROW ROBERT (Chief Executive Officer) sold 3.1% of their position (26.49K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $180.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2025ACC: 0000950170-25-090428
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-26.49K
Net shares
Net seller
$180.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
26.49K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−26.49K
Price / share
$6.80
Trade value
$180.14K
% of position
3.1%
6/25/2025
856.56K→830.07K
Total
Net shares
−26.49K
Net value
-$180.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/25/2025 | S · Sale | −26.49K | $6.80 | $180.14K | 3.1% | 856.56K | 830.07K |
| Total | −26.49K | -$180.14K | ||||||
Derivative Transactions0
No derivative transactions reported